HIF-1-alpha and survivin involved in the antiapoptotic effect of 2ME2 after global ischemia in rats

Neurological Research

Volumn 33, Issue 6, 2011, Pages 583-592

  Li, Yun ^a,b   Xia, Zuo Li ^a,c   Chen, Lian Bi ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

2ME2; Caspase 3; Global ischemia; HIF 1 alpha; Survivin

Indexed keywords

2 METHOXYESTRADIOL; CASPASE 3; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SURVIVIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD VESSEL OCCLUSION; BRAIN ISCHEMIA; CELL LOSS; CONTROLLED STUDY; GLOBAL ISCHEMIA; HIPPOCAMPUS; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BRAIN ISCHEMIA; DOWN-REGULATION; ESTRADIOL; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICROTUBULE-ASSOCIATED PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 79959694876     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/1743132810Y.0000000013     Document Type: Article

References (44)

1. Block F. Global ischemia and behavioural deficits. Prog Neurobiol 1999;58(3):279-95.
2. Martin LJ, Al-Abdulla NA, Brambrink AM, Kirsch JR, Sieber FE, Portera-Cailliau C. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res Bull 1998;46(4):281-309.
3. Chauhan N, Zhao Z, Barber PA, Buchan AM. Lessons in experimental ischemia for clinical stroke medicine. Curr Opin Neurol 2003;16(1):65-71.
4. Sterz F, Holzer M, Roine R, Zeiner A, Losert H, Eisenburger P, et al. Hypothermia after cardiac arrest: a treatment that works. Curr Opin Crit Care 2003;9(3):205-10.
5. Li Y, Zhou C, Calvert JW, Colohan AR, Zhang JH. Multiple effects of hyperbaric oxygen on the expression of HIF-1 alpha and apoptotic genes in a global ischemia-hypotension rat model. Exp Neurol 2005;191(1):198-210.
6. Badr AE, Yin W, Mychaskiw G, Zhang JH. Effect of hyperbaric oxygen on striatal metabolites: a microdialysis study in awake freely moving rats after MCA occlusion. Brain Res 2001;916(1-2):85-90.
7. Yin D, Zhou C, Kusaka I, Calvert JW, Parent AD, Nanda A, et al. Inhibition of apoptosis by hyperbaric oxygen in a rat focal cerebral ischemic model. J Cereb Blood Flow Metab 2003;23(7):855-64.
8. Buras J. Basic mechanisms of hyperbaric oxygen in the treatment of ischemia-reperfusion injury. Int Anesthesiol Clin 2000;38(1):91-109.
9. Bergeron M, Yu AY, Solway KE, Semenza GL, Sharp FR. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci 1999;11(12):4159-70.
10. Chavez JC, LaManna JC. Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1. J Neurosci 2002;22(20):8922-31.
11. Jin KL, Mao XO, Nagayama T, Goldsmith PC, Greenberg DA. Induction of vascular endothelial growth factor and hypoxia-inducible factor-1alpha by global ischemia in rat brain. Neuroscience 2000;99(3):577-85.
12. Halterman MW, Federoff HJ. HIF-1alpha and p53 promote hypoxia-induced delayed neuronal death in models of CNS ischemia. Exp Neurol 1999;159(1):65-72.
13. Yu R, Gao L, Jiang S, Guan P, Mao B. Association of HIF-1alpha expression and cell apoptosis after traumatic brain injury in the rat. Chin J Traumatol 2001;4(4):218-21.
14. Brune B, von Knethen A, Sandau KB. Transcription factors p53 and HIF-1alpha as targets of nitric oxide. Cell Signal 2001;13(8):525-33.
15. Goda N, Dozier SJ, Johnson RS. HIF-1 in cell cycle regulation, apoptosis, and tumor progression. Antioxid Redox Signal 2003;5(4):467-73.
16. Moritz W, Meier F, Stroka DM, Giuliani M, Kugelmeier P, Nett PC, et al. Apoptosis in hypoxic human pancreatic islets correlates with HIF-1alpha expression. FASEB J 2002; 16(7):745-7.
17. Gottlieb TM, Oren M. p53 and apoptosis. Semin Cancer Biol 1998;8(5):359-68.
18. Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 2003;3(4):363-75.
19. Hagen T, D'Amico G, Quintero M, Palacios-Callender M, Hollis V, Lam F, et al. Inhibition of mitochondrial respiration by the anticancer agent 2-methoxyestradiol. Biochem Biophys Res Commun 2004;322(3):923-9.
20. Chen C, Hu Q, Yan J, Lei J, Qin L, Shi X, et al. Multiple effects of 2ME2 and D609 on the cortical expression of HIF-1alpha and apoptotic genes in a middle cerebral artery occlusioninduced focal ischemia rat model. J Neurochem 2007; 102(6):1831-41.
21. Villapol S, Acarin L, Faiz M, Castellano B, Gonzalez B. Survivin and heat shock protein 25/27 colocalize with cleaved caspase-3 in surviving reactive astrocytes following excitotoxicity to the immature brain. Neuroscience 2008; 153(1):108-19.
22. Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI, et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and-7. Biochemistry 2001;40(4):1117-23.
23. Pulsinelli WA, Brierley JB. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 1979; 10(3):267-72.
24. Picazo O, Azcoitia I, Garcia-Segura LM. Neuroprotective and neurotoxic effects of estrogens. Brain Res 2003;990(1-2):20-7.
25. Zhou C, Li Y, Nanda A, Zhang JH. HBO suppresses Nogo-A, Ng-R, or RhoA expression in the cerebral cortex after global ischemia. Biochem Biophys Res Commun 2003; 309(2):368-76.
26. Tayapiwatana C, Chotpadiwetkul R, Kasinrerk W. A novel approach using streptavidin magnetic bead-sorted in vivo biotinylated survivin for monoclonal antibody production. J Immunol Methods 2006;317(1-2):1-11.
27. Conway EM, Zwerts F, Van Eygen V, DeVriese A, Nagai N, Luo W, et al. Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxia-induced up-regulation. Am J Pathol 2003;163(3):935-46.
28. Calvert JW, Yin W, Patel M, Badr A, Mychaskiw G, Parent AD, et al. Hyperbaric oxygenation prevented brain injury induced by hypoxia-ischemia in a neonatal rat model. Brain Res 2002;951(1):1-8.
29. Peng XH, Karna P, Cao Z, Jiang BH, Zhou M, Yang L. Crosstalk between epidermal growth factor receptor and hypoxiainducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem 2006;281(36):25903-14.
30. Semenza GL. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 2001;7(8):345-50.
31. Li L, Xiong Y, Qu Y, Mao M, Mu W, Wang H, et al. The requirement of extracellular signal-related protein kinase pathway in the activation of hypoxia inducible factor 1 alpha in the developing rat brain after hypoxia-ischemia. Acta Neuropathol 2008;115(3):297-303.
32. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 1998;58(23):5315-20.
33. Banasiak KJ, Haddad GG. Hypoxia-induced apoptosis: effect of hypoxic severity and role of p53 in neuronal cell death. Brain Res 1998;797(2):295-304.
34. Piret JP, Mottet D, Raes M, Michiels C. Is HIF-1alpha a proor an anti-apoptotic protein? Biochem Pharmacol 2002;64(5-6):889-92.
35. Chen W, Jadhav V, Tang J, Zhang JH. HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model. Neurobiol Dis 2008;31(3):433-41.
36. Helton R, Cui J, Scheel JR, Ellison JA, Ames C, Gibson C, et al. Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage. J Neurosci 2005;25(16):4099-107.
37. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3(8):917-21.
38. Johnson EA, Svetlov SI, Wang KK, Hayes RL, Pineda JA. Cell-specific DNA fragmentation may be attenuated by a survivin-dependent mechanism after traumatic brain injury in rats. Exp Brain Res 2005;167(1):17-26.
39. Kappler M, Taubert H, Holzhausen HJ, Reddemann R, Rot S, Becker A, et al. Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer: prognostic role and correlation with tumor markers and tumor oxygenation parameters. Strahlenther Onkol 2008; 184(8):393-9.
40. Bache M, Holzapfel D, Kappler M, Holzhausen HJ, Taubert H, Dunst J, et al. Survivin protein expression and hypoxia in advanced cervical carcinoma of patients treated by radiotherapy. Gynecol Oncol 2007;104(1):139-44.
41. Mun J, Wang Y, Voll RJ, Escuin-Borras D, Giannakakou P, Goodman MM. Syntheses and biological activities of novel 2-methoxyestradiol analogs, 2-fluoroethoxyestradiol and 2-fluoropropanoxyestradiol, and a radiosynthesis of 2-[(18)F] fluoroethoxyestradiol for positron emission tomography. Nucl Med Biol 2008;35(5):615-22.
42. Park J, Franco RS, Augsburger JJ, Banerjee RK. Comparison of 2-methoxyestradiol and methotrexate effects on non-Hodgkin's B-cell lymphoma. Curr Eye Res 2007;32(7-8):659-67.
43. Hua K, Din J, Cao Q, Feng W, Zhang Y, Yao L, et al. Estrogen and progestin regulate HIF-1alpha expression in ovarian cancer cell lines via the activation of Akt signaling transduction pathway. Oncol Rep 2009;21(4):893-8.
44. Lakhani NJ, Sarkar MA, Venitz J, Figg WD. 2-methoxyestradiol, a promising anticancer agent. Pharmacotherapy 2003; 23(2):165-72.